Evidence map›Paper›PMID 31960544›Full record

ArticleAddiction biology2021

Fatty acid amide hydrolase is lower in young cannabis users.

Maya R Jacobson, Jeremy J Watts, Tania Da Silva, Rachel F Tyndale, Pablo M Rusjan, Sylvain Houle, Alan A Wilson, Ruth A Ross, Isabelle Boileau, Romina Mizrahi

Open access · greenAbstract read
In one paragraph

Article in Addiction biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Review
  3. FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  4. Cannabis produces acute hyperphagia in humans and rodents via increased reward valuation for, and motivation to, acquire food.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Cannabis use disorder: from neurobiology to treatment.The Journal of clinical investigation · 2024
    Review
  9. Article
  10. Frontiers in neuroinformatics · 2024
    Article
  11. Review
  12. Review
  13. Genes · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Maya R JacobsonResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Jeremy J WattsResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.ORCID 0000-0003-1751-5409
Tania Da SilvaResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Rachel F TyndaleDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-1297-2053
Pablo M RusjanResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Sylvain HouleResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Alan A WilsonResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Ruth A RossDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
Isabelle BoileauResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Romina MizrahiResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.ORCID 0000-0001-6667-7928
Centre for Addiction and Mental Health · CAUniversity of Toronto · CA

Funding

Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode PsychosisR01MH113564 · NIMH · MCGILL UNIVERSITY · PI MIZRAHI, ROMINA · 2017 to 2022
$2.2M
Imaging Neuroinflammation in Clinical high risk and SchizophreniaR01MH100043 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI MIZRAHI, ROMINA · 2014 to 2018
$1.6M
Imaging Alterations in Endocannabinoid Metabolism in SchizophreniaR21MH103717 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI MIZRAHI, ROMINA · 2014 to 2015
$294k
NIMH NIH HHS 1R21MH103717-01A1NIMH NIH HHS R01 MH100043NIMH NIH HHS R01 MH113564NIMH NIH HHS R21 MH103717
6 · The paper itself

Abstract

We have recently shown that levels of fatty acid amide hydrolase (FAAH), the enzyme that metabolizes the endocannabinoid anandamide, are lower in the brains of adult cannabis users (CUs) (34 ± 11 years of age), tested during early abstinence. Here, we examine replication of the lower FAAH levels in a separate, younger cohort (23 ± 5 years of age). Eighteen healthy volunteers (HVs) and fourteen CUs underwent a positron emission tomography scan using the FAAH radioligand [

Indexed as

AdolescentAdultAmidohydrolasesBrainCannabisFatty Acid Amide HydrolasesFemaleHumansMaleMarijuana UseOntarioPositron-Emission TomographyYoung AdultAmidohydrolasesFatty Acid Amide Hydrolases[11C]CURBaddictionanandamidecannabisfatty acid amide hydrolasepositron emission tomography

Identifiers

PMID31960544
PMCPMC7944390
OpenAlexW3002634800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.